Related Experiment Video
Updated: Aug 12, 2026
Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
Published on: May 10, 2024
Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats
1Department of Women and Child Health, Karolinska Institute, Karolinska Hospital, Stockholm, Sweden.
Abstract:
The development and progression of diabetic nephropathy is dependent on glucose homeostasis and many other contributing factors. In the present study, we examined the effect of nitecapone, an inhibitor of the dopamine-metabolizing enzyme catechol-O-methyl transferase (COMT) and a potent antioxidant, on functional and cellular determinants of renal function in rats with streptozotocin-induced diabetes. Administration of nitecapone to diabetic rats normalized urinary sodium excretion in a manner consistent with the dopamine-dependent inhibition of proximal tubule Na,K-ATPase activity. Hyperfiltration, focal glomerulosclerosis, and albuminuria were also reversed by nitecapone, but in a manner that is more readily attributed to the antioxidant potential of the agent. A pattern of elevated oxidative stress, measured as CuZn superoxide dismutase gene expression and thiobarbituric acid-reactive substance content, was noted in diabetic rats, and both parameters were normalized by nitecapone treatment. In diabetic rats, activation of glomerular protein kinase C (PKC) was confirmed by isoform-specific translocation and Ser23 phosphorylation of the PKC substrate Na,K-ATPase. PKC-dependent changes in Na,K-ATPase phosphorylation were associated with decreased glomerular Na,K-ATPase activity. Nitecapone-treated diabetic rats were protected from these intracellular modifications. The combined results suggest that the COMT-inhibitory and antioxidant properties of nitecapone provide a protective therapy against the development of diabetic nephropathy.
Insights
Nitecapone, a catechol-O-methyl transferase (COMT) inhibitor and antioxidant, reversed key markers of diabetic nephropathy in rats. This suggests nitecapone
Area of Science:
- Nephrology
- Pharmacology
- Biochemistry
Background:
- Diabetic nephropathy is a major complication of diabetes mellitus.
- Glucose homeostasis and oxidative stress contribute to its development.
- Catechol-O-methyl transferase (COMT) and protein kinase C (PKC) pathways are implicated.
Purpose of the Study:
- To investigate the therapeutic effects of nitecapone on diabetic nephropathy.
- To assess nitecapone's impact on renal function and cellular markers in diabetic rats.
- To explore the roles of COMT inhibition and antioxidant properties in nitecapone's action.
Main Methods:
- Streptozotocin-induced diabetes model in rats.
- Administration of nitecapone to diabetic rats.
- Assessment of urinary sodium excretion, hyperfiltration, glomerulosclerosis, and albuminuria.
- Measurement of oxidative stress markers (CuZn superoxide dismutase gene expression, thiobarbituric acid-reactive substances).
- Analysis of glomerular protein kinase C (PKC) activation and Na,K-ATPase phosphorylation.
Main Results:
- Nitecapone normalized urinary sodium excretion, suggesting dopamine-dependent effects on Na,K-ATPase.
- Hyperfiltration, glomerulosclerosis, and albuminuria were reversed by nitecapone, indicating antioxidant benefits.
- Nitecapone treatment normalized elevated oxidative stress markers in diabetic rats.
- PKC-dependent activation and altered phosphorylation of Na,K-ATPase in diabetic rats were prevented by nitecapone.
Conclusions:
- Nitecapone exhibits protective effects against diabetic nephropathy in rats.
- Both COMT inhibition and antioxidant properties contribute to nitecapone's renoprotective effects.
- Nitecapone may represent a novel therapeutic strategy for managing diabetic nephropathy.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
